Wafa Y Madanat1, Khaldoon M Alawneh2, Mahmoud M Smadi3, Salwa S Saadeh2, Muntasser M Omari2, Anas B Bani Hani2, Hasan Yazici4. 1. Medical Department, Jordan's Friends of Behçet's Disease Patients Society, Amman, Jordan. wmadanat@orange.jo. 2. Department of Medicine, King Abdullah Hospital, Jordan University of Science and Technology, Irbid, Jordan. 3. Department of Mathematics and Statistics, Jordan University of Science and Technology, Irbid, Jordan. 4. Cerrahpaşa Hospital, University of Istanbul, Turkey.
Abstract
OBJECTIVES: To estimate the prevalence of Behçet's disease (BD) in Jordan, with the additional aim of comparing this prevalence among hospital workers in other geographical areas. METHODS: In the first stage of our survey, 2,569 employees from 6 hospitals in north Jordan were interviewed using a screening questionnaire to identify individuals with recurrent oral ulcers (ROU), a previous diagnosis of BD (PDBD) and/or any major symptom related to BD. In the second stage, all individuals with ROU or PDBD identified at stage 1, were examined by 2 rheumatologists for the presence/confirmation of BD according to the International Study Group (ISG) criteria. Pathergy test was performed according to recommendations. RESULTS: ROU were present in 210 (8.2%) individuals. BD was confirmed in 10 employees with PDBD. Seven more BD patients were found. Mean age of 17 BD patients was 38.6±10.7 (range 26-65 y). M: F was 2.4:1. Pathergy test was positive in 8/17. A family history of ROU or BD was noted in 9 (52%) and 3 (25.0%), respectively, compared to 227 (8.9%) and 62 (2.6%) in the whole group, excluding the BD patients (p<0.001 and 0.008, respectively). The prevalence rate of BD in the north of Jordan was estimated as 66:10.000 (95% CI 34.8 to 97.5:10000). CONCLUSIONS: The results of this first ever survey indicated that the prevalence of BD in the north of Jordan is among the highest in the world. This prevalence can now be compared to hospital workers in other geographical areas.
OBJECTIVES: To estimate the prevalence of Behçet's disease (BD) in Jordan, with the additional aim of comparing this prevalence among hospital workers in other geographical areas. METHODS: In the first stage of our survey, 2,569 employees from 6 hospitals in north Jordan were interviewed using a screening questionnaire to identify individuals with recurrent oral ulcers (ROU), a previous diagnosis of BD (PDBD) and/or any major symptom related to BD. In the second stage, all individuals with ROU or PDBD identified at stage 1, were examined by 2 rheumatologists for the presence/confirmation of BD according to the International Study Group (ISG) criteria. Pathergy test was performed according to recommendations. RESULTS: ROU were present in 210 (8.2%) individuals. BD was confirmed in 10 employees with PDBD. Seven more BD patients were found. Mean age of 17 BD patients was 38.6±10.7 (range 26-65 y). M: F was 2.4:1. Pathergy test was positive in 8/17. A family history of ROU or BD was noted in 9 (52%) and 3 (25.0%), respectively, compared to 227 (8.9%) and 62 (2.6%) in the whole group, excluding the BD patients (p<0.001 and 0.008, respectively). The prevalence rate of BD in the north of Jordan was estimated as 66:10.000 (95% CI 34.8 to 97.5:10000). CONCLUSIONS: The results of this first ever survey indicated that the prevalence of BD in the north of Jordan is among the highest in the world. This prevalence can now be compared to hospital workers in other geographical areas.
Authors: Jurgen Sota; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Ida Orlando; Gian Marco Tosi; Bruno Frediani; Antonio Vitale; Silvana Guerriero; Florenzo Iannone; Lorenzo Vannozzi; Claudia Fabiani; Luca Cantarini Journal: Intern Emerg Med Date: 2020-02-01 Impact factor: 3.397
Authors: Claudia Fabiani; Luca Cantarini; Antonio Vitale; Francesca Della Casa; Gaafar Ragab; Ibrahim A Almaghlouth; Giuseppe Lopalco; Rosa Maria Pereira; Silvana Guerriero; Marcello Govoni; Petros P Sfikakis; Roberto Giacomelli; Francesco Ciccia; Sara Monti; Piero Ruscitti; Matteo Piga; Claudia Lomater; Abdurrahman Tufan; Daniela Opris-Belinski; Giacomo Emmi; José Hernández-Rodríguez; Ali Şahin; Gian Domenico Sebastiani; Elena Bartoloni; Nurullah Akkoç; Özgül Soysal Gündüz; Marco Cattalini; Giovanni Conti; Gulen Hatemi; Armin Maier; Paola Parronchi; Emanuela Del Giudice; Sukran Erten; Antonella Insalaco; Francesca Li Gobbi; Maria Cristina Maggio; Farhad Shahram; Valeria Caggiano; Mohamed Tharwat Hegazy; Kazi Nur Asfina; Maria Morrone; Leandro L Prado; Rosanna Dammacco; Francesca Ruffilli; Aikaterini Arida; Luca Navarini; Ilenia Pantano; Lorenzo Cavagna; Alessandro Conforti; Alberto Cauli; Elena Maria Marucco; Hamit Kucuk; Ruxandra Ionescu; Irene Mattioli; Gerard Espinosa; Olga Araújo; Burak Karkaş; Claudia Canofari; Jurgen Sota; Ahmed Hatem Laymouna; Asma A Bedaiwi; Sergio Colella; Henrique Ayres M Giardini; Valeria Albano; Andrea Lo Monaco; George E Fragoulis; Riza Can Kardas; Virginia Berlengiero; Mohamed A Hussein; Francesca Ricci; Francesco La Torre; Donato Rigante; Ewa Więsik-Szewczyk; Micol Frassi; Stefano Gentileschi; Gian Marco Tosi; Marilia Ambiel Dagostin; Ayman Abdel-Monem Ahmed Mahmoud; Maria Tarsia; Giovanni Alessio; Rolando Cimaz; Teresa Giani; Carla Gaggiano; Florenzo Iannone; Paola Cipriani; Mariam Mourabi; Veronica Spedicato; Sara Barneschi; Emma Aragona; Alberto Balistreri; Bruno Frediani Journal: Intern Emerg Med Date: 2022-07-14 Impact factor: 5.472